ImmunityBio Founder Dr. Patrick Soon-Shiong Recognized as One of “100 Most Influential People in Oncology in 2025”

Core Viewpoint - ImmunityBio, Inc. has announced that Dr. Patrick Soon-Shiong has been recognized as one of "The 100 Most Influential People in Oncology in 2025" by OncoDaily, highlighting his significant contributions to the field of oncology and the company's mission towards a cancer-free society [1] Company Summary - ImmunityBio, Inc. is a commercial-stage immunotherapy company focused on advancing cancer treatment [1] - Dr. Patrick Soon-Shiong serves as the Founder, Executive Chairman, and Global Chief Scientific and Medical Officer of ImmunityBio [1] Industry Summary - The recognition of Dr. Soon-Shiong underscores the importance of leadership and innovation in the oncology sector, reflecting the ongoing efforts to improve cancer therapies and outcomes [1]